Delivery Order SPE2DR25D1116-SPE2DR26FTF5G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,817.44 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and...
- The Defense Logistics Agency awarded a delivery order valued at $38,258.58 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an...
- The Defense Logistics Agency awarded a delivery order valued at $34,433.39 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The product is an antimalarial medication commonly used for malaria...
- The Defense Logistics Agency awarded a delivery order valued at $25,275.80 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with a completion date of June 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.20 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atovaquone-Proguanil 250-100 (100 tablets). This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was competitively procured. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,244.44 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award,...
- The Defense Logistics Agency awarded a delivery order valued at $1,586.54 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The product being...
- SPE2DR25D1116Indefinite Delivery Contract
- SPE2DR25D1116-SPE2DR26FTF5GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $29,337.37 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 mg in quantities of 100 tablets. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract was executed on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion vehicle that runs through December 2026 and serves as the primary global pharmaceutical support mechanism for military healthcare systems. AmerisourceBergen is a major pharmaceutical distributor that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The Atovaquone-Proguanil product supplied under this order is an antimalarial medication commonly used for malaria prophylaxis and treatment by military personnel deployed to endemic regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 12/1/25 |